Clene (CLNN) Short Interest Ratio & Short Volume → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free CLNN Stock Alerts $0.39 0.00 (0.00%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Clene Short Interest DataCurrent Short Volume148,500 sharesPrevious Short Volume162,900 sharesChange Vs. Previous Month-8.84%Dollar Volume Sold Short$49,212.90Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares128,430,000 sharesPercentage of Shares Shorted0.12%Today's Trading Volume454,635 sharesAverage Trading Volume927,845 sharesToday's Volume Vs. Average49% Short Selling Clene ? Sign up to receive the latest short interest report for Clene and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatCLNN Short Interest Over TimeCLNN Days to Cover Over TimeCLNN Percentage of Float Shorted Over Time Ad Crypto 101 MediaTech GIANT’s Plans to Revolutionize Crypto…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Clene Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024148,500 shares $49,212.90 -8.8%N/A0.2 $0.33 3/31/2024162,900 shares $69,297.66 -37.9%N/A0.2 $0.43 3/15/2024262,500 shares $105,000.00 -38.5%N/A0.2 $0.40 2/29/2024427,100 shares $171,865.04 +86.8%N/A0.4 $0.40 2/15/2024228,700 shares $105,224.87 +2.9%N/A0.2 $0.46 1/31/2024222,300 shares $109,816.20 -22.6%N/A0.2 $0.49 Get the Latest News and Ratings for CLNN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Clene and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024287,200 shares $137,798.56 -66.1%N/A0.3 $0.48 12/31/2023846,000 shares $250,923.60 +91.5%N/A1 $0.30 12/15/2023441,800 shares $185,644.36 -25.5%N/A0.7 $0.42 11/30/2023592,800 shares $259,646.40 +1.9%N/A1.4 $0.44 11/15/2023581,900 shares $256,617.90 -15.4%N/A1.4 $0.44 10/31/2023687,500 shares $268,125.00 -13.0%N/A1.7 $0.39 10/15/2023790,600 shares $402,415.40 -2.0%N/A1.9 $0.51 9/30/2023806,900 shares $400,141.71 +52.1%N/A1.8 $0.50 9/15/2023530,500 shares $286,470.00 +29.3%N/A1 $0.54 8/31/2023410,400 shares $295,488.00 -28.4%N/A0.7 $0.72 8/15/2023572,800 shares $426,736.00 -4.3%N/A1.1 $0.75 7/31/2023598,300 shares $464,280.80 -47.5%2.5%1.2 $0.78 7/15/20231,140,000 shares $912,114.00 -2.6%4.8%2.4 $0.80 6/30/20231,170,000 shares $1.03 million -28.7%4.8%2.7 $0.88 6/15/20231,640,000 shares $1.72 million -8.4%5.5%5.2 $1.05 5/31/20231,790,000 shares $1.74 million +1.1%5.8%7 $0.97 5/15/20231,770,000 shares $1.58 million -4.8%5.8%5.6 $0.90 4/30/20231,860,000 shares $1.77 million -1.1%6.2%1.8 $0.95 4/15/20231,880,000 shares $1.97 million +2.7%6.2%1.8 $1.05 3/31/20231,830,000 shares $2.07 million -16.4%6.5%1.8 $1.13 3/15/20232,190,000 shares $2.87 million +17.1%7.8%2.1 $1.31 2/28/20231,870,000 shares $2.36 million -37.9%6.7%2 $1.26 2/15/20233,010,000 shares $3.82 million +64.5%11.1%3.4 $1.27 1/31/20231,830,000 shares $2.80 million -19.0%6.8%9.7 $1.53 1/15/20232,260,000 shares $2.96 million -0.9%8.3%8.8 $1.31 12/30/20222,280,000 shares $2.28 million -5.4%8.7%9 $1.00 12/15/20222,410,000 shares $2.68 million -3.6%9.2%6.7 $1.11 11/30/20222,500,000 shares $2.65 million -8.4%13.5%7.2 $1.06 11/15/20222,730,000 shares $2.87 million -19.2%14.7%7.6 $1.05 10/31/20223,380,000 shares $3.35 million +13.0%18.0%8.8 $0.99 10/15/20222,990,000 shares $4.49 million -25.4%14.1%8.9 $1.50 9/30/20224,010,000 shares $11.23 million No Change18.9%3.3 $2.80 9/15/20224,010,000 shares $12.03 million +2.3%18.9%3.3 $3.00 8/31/20223,920,000 shares $11.60 million +25.6%15.3%3.2 $2.96READ THIS – If You Missed Out On The AI Boom (Ad)Adam’s research shows a radical new technology is set to grow 10X faster than the internet … and drastically alter manufacturing, healthcare, agriculture … even energy. Nvidia’s CEO said it will be, “flat out, the biggest [tech] revolution ever.”Click on Adam's shiny forehead for more details. CLNN Short Interest - Frequently Asked Questions What is Clene's current short interest? Short interest is the volume of Clene shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 148,500 shares of CLNN short. Learn More on Clene's current short interest. Which institutional investors are shorting Clene? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Clene: CVI Holdings LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Clene's short interest increasing or decreasing? Clene saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 148,500 shares, a drop of 8.8% from the previous total of 162,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Clene's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Clene: Ocuphire Pharma, Inc. (6.17%), Aadi Bioscience, Inc. (6.31%), HCW Biologics Inc. (0.05%), Gain Therapeutics, Inc. (1.10%), Rockwell Medical, Inc. (2.40%), Xilio Therapeutics, Inc. (4.35%), Immuneering Co. (13.23%), BioLineRx Ltd. (0.98%), Sensei Biotherapeutics, Inc. (0.50%), Eledon Pharmaceuticals, Inc. (0.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Clene stock? Short selling CLNN is an investing strategy that aims to generate trading profit from Clene as its price is falling. CLNN shares are trading down $0.00 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Clene? A short squeeze for Clene occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CLNN, which in turn drives the price of the stock up even further. How often is Clene's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CLNN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Ocuphire Pharma Short Interest Data Aadi Bioscience Short Interest Data HCW Biologics Short Interest Data Gain Therapeutics Short Interest Data Rockwell Medical Short Interest Data Xilio Therapeutics Short Interest Data Immuneering Short Interest Data BioLineRx Short Interest Data Sensei Biotherapeutics Short Interest Data Eledon Pharmaceuticals Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:CLNN) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward PressThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold